======= IKBKG =======
== Gene Information ==
* **Official Symbol**: IKBKG
* **Official Name**: inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8517|8517]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y6K9|Q9Y6K9]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=IKBKG&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20IKBKG|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/300248|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes the regulatory subunit of the inhibitor of kappaB kinase (IKK) complex, which activates NF-kappaB resulting in activation of genes involved in inflammation, immunity, cell survival, and other pathways. Mutations in this gene result in incontinentia pigmenti, hypohidrotic ectodermal dysplasia, and several other types of immunodeficiencies. A pseudogene highly similar to this locus is located in an adjacent region of the X chromosome. [provided by RefSeq, Mar 2016]. COMPLETENESS: complete on the 3' end.
* **UniProt Summary**: Regulatory subunit of the IKK core complex which phosphorylates inhibitors of NF-kappa-B thus leading to the dissociation of the inhibitor/NF-kappa-B complex and ultimately the degradation of the inhibitor. Its binding to scaffolding polyubiquitin seems to play a role in IKK activation by multiple signaling receptor pathways. However, the specific type of polyubiquitin recognized upon cell stimulation (either 'Lys-63'- linked or linear polyubiquitin) and its functional importance is reported conflictingly. Also considered to be a mediator for TAX activation of NF-kappa-B. Could be implicated in NF-kappa-B- mediated protection from cytokine toxicity. Essential for viral activation of IRF3. Involved in TLR3- and IFIH1-mediated antiviral innate response; this function requires 'Lys-27'-linked polyubiquitination. {ECO:0000269|PubMed:14695475, ECO:0000269|PubMed:19854139, ECO:0000269|PubMed:20724660}.
|NEMO|
|linear polyubiquitin binding|
|IkappaB kinase complex|
|anoikis|
|peroxisome proliferator activated receptor binding|
|K63-linked polyubiquitin modification-dependent protein binding|
|nucleotide-binding oligomerization domain containing signaling pathway|
|nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway|
|TRIF-dependent toll-like receptor signaling pathway|
|MyD88-independent toll-like receptor signaling pathway|
|cytoplasmic pattern recognition receptor signaling pathway|
|regulation of tumor necrosis factor-mediated signaling pathway|
|positive regulation of macroautophagy|
|I-kappaB kinase/NF-kappaB signaling|
|antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent|
|mitotic spindle|
|antigen processing and presentation of exogenous peptide antigen via MHC class I|
|JNK cascade|
|intracellular|
|interleukin-1-mediated signaling pathway|
|antigen processing and presentation of peptide antigen via MHC class I|
|toll-like receptor signaling pathway|
|stress-activated MAPK cascade|
|ubiquitin ligase complex|
|stimulatory C-type lectin receptor signaling pathway|
|innate immune response activating cell surface receptor signaling pathway|
|positive regulation of autophagy|
|spindle pole|
|pattern recognition receptor signaling pathway|
|stress-activated protein kinase signaling cascade|
|positive regulation of NF-kappaB transcription factor activity|
|activation of MAPK activity|
|regulation of cytokine-mediated signaling pathway|
|intracellular receptor signaling pathway|
|regulation of macroautophagy|
|Fc-epsilon receptor signaling pathway|
|cellular response to interleukin-1|
|establishment of vesicle localization|
|regulation of response to cytokine stimulus|
|T cell receptor signaling pathway|
|antigen processing and presentation of exogenous peptide antigen|
|antigen processing and presentation of exogenous antigen|
|positive regulation of I-kappaB kinase/NF-kappaB signaling|
|vesicle localization|
|antigen processing and presentation of peptide antigen|
|response to interleukin-1|
|negative regulation of neuron death|
|antigen processing and presentation|
|innate immune response-activating signal transduction|
|regulation of I-kappaB kinase/NF-kappaB signaling|
|Fc receptor signaling pathway|
|protein domain specific binding|
|activation of innate immune response|
|positive regulation of DNA-binding transcription factor activity|
|positive regulation of MAP kinase activity|
|response to virus|
|protein deubiquitination|
|ubiquitin protein ligase binding|
|antigen receptor-mediated signaling pathway|
|protein modification by small protein removal|
|regulation of neuron death|
|activation of protein kinase activity|
|regulation of autophagy|
|positive regulation of protein serine/threonine kinase activity|
|positive regulation of innate immune response|
|regulation of MAP kinase activity|
|positive regulation of response to biotic stimulus|
|establishment of organelle localization|
|positive regulation of cellular catabolic process|
|MAPK cascade|
|signal transduction by protein phosphorylation|
|regulation of DNA-binding transcription factor activity|
|positive regulation of catabolic process|
|immune response-activating cell surface receptor signaling pathway|
|regulation of innate immune response|
|positive regulation of defense response|
|immune response-regulating cell surface receptor signaling pathway|
|protein heterodimerization activity|
|inflammatory response|
|positive regulation of multi-organism process|
|regulation of protein serine/threonine kinase activity|
|regulation of response to biotic stimulus|
|positive regulation of protein kinase activity|
|positive regulation of MAPK cascade|
|immune response-activating signal transduction|
|positive regulation of kinase activity|
|organelle localization|
|immune response-regulating signaling pathway|
|positive regulation of response to external stimulus|
|activation of immune response|
|positive regulation of transferase activity|
|cytokine-mediated signaling pathway|
|viral process|
|regulation of MAPK cascade|
|regulation of defense response|
|innate immune response|
|cellular response to DNA damage stimulus|
|regulation of multi-organism process|
|symbiotic process|
|regulation of protein kinase activity|
|interspecies interaction between organisms|
|regulation of cellular catabolic process|
|positive regulation of immune response|
|regulation of kinase activity|
|protein homodimerization activity|
|apoptotic process|
|defense response to other organism|
|protein phosphorylation|
|regulation of transferase activity|
|protein modification by small protein conjugation or removal|
|negative regulation of cell death|
|regulation of catabolic process|
|cellular response to cytokine stimulus|
|positive regulation of protein phosphorylation|
|positive regulation of intracellular signal transduction|
|programmed cell death|
|positive regulation of phosphorylation|
|identical protein binding|
|cell death|
|regulation of response to external stimulus|
|response to cytokine|
|positive regulation of phosphorus metabolic process|
|positive regulation of phosphate metabolic process|
|positive regulation of immune system process|
|regulation of immune response|
|positive regulation of transcription by RNA polymerase II|
|positive regulation of protein modification process|
|proteolysis|
|phosphorylation|
|response to other organism|
|response to external biotic stimulus|
|response to biotic stimulus|
|defense response|
|positive regulation of catalytic activity|
|regulation of protein phosphorylation|
|regulation of response to stress|
|positive regulation of transcription, DNA-templated|
|regulation of phosphorylation|
|positive regulation of cellular protein metabolic process|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|regulation of immune system process|
|positive regulation of signal transduction|
|regulation of cell death|
|intracellular signal transduction|
|cellular response to stress|
|positive regulation of protein metabolic process|
|positive regulation of RNA metabolic process|
|positive regulation of molecular function|
|regulation of phosphate metabolic process|
|regulation of phosphorus metabolic process|
|positive regulation of cell communication|
|positive regulation of signaling|
|regulation of intracellular signal transduction|
|establishment of localization in cell|
|regulation of protein modification process|
|immune response|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp533|TNF-alpha 44ng/ml R08 exp533]]|-3.4|
|[[:results:exp19|Etoposide 1μM R00 exp19]]|-1.95|
^Gene^Correlation^
|[[:human genes:p:polr2j3|POLR2J3]]|0.433|
Global Fraction of Cell Lines Where Essential: 2/694
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/26|
|bone|0/26|
|breast|0/30|
|central nervous system|0/49|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/11|
|fibroblast|0/1|
|gastric|0/14|
|kidney|0/18|
|liver|0/19|
|lung|0/72|
|lymphocyte|0/16|
|ovary|0/25|
|pancreas|0/22|
|peripheral nervous system|0/15|
|plasma cell|0/12|
|prostate|0/1|
|skin|0/20|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/28|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 11897
* **Expression level (log2 read counts)**: 4.56
{{:chemogenomics:nalm6 dist.png?nolink |}}